找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: New Antimicrobials: For the Present and the Future; I.W. Fong Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive l

[复制链接]
查看: 8534|回复: 52
发表于 2025-3-21 19:45:29 | 显示全部楼层 |阅读模式
书目名称New Antimicrobials: For the Present and the Future
编辑I.W. Fong
视频video
概述Summarizes the last decade of advances in antibiotics, antivirals, antifungals, and antiparasitic agents.Details pharmacology, chemical nature, antimicrobial spectrum, dosage, efficacy, and more for e
丛书名称Emerging Infectious Diseases of the 21st Century
图书封面Titlebook: New Antimicrobials: For the Present and the Future;  I.W. Fong Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive l
描述This is a timely and essential companion to the recently published .Antimicrobial Resistance in the 21st Century, Second Edition. .Antimicrobial resistance is a major threat to global population health, with government reports projecting it could result in over 10 million deaths in the next 35 years. Development of new agents to combat this threat is one of the WHO‘s top priorities, but in 2017, it conceded that the current drug development pipeline was insufficient to mitigate the threat. This book discusses recent progress and bolster new agent discovery and development, by providing researchers and students who will soon enter the field with a thorough guide to the advancements made in the last decade. .Coverage includes new systemic antimicrobials approved since 2010, with detailed analysis of antibiotics, antivirals, antifungals, and antiparasitics, as well as agents in development for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparis
出版日期Book 2023
关键词antimicrobial resistance; antimicrobial agents; antibiotic; antifungal; antiparasitic; systemic infection
版次1
doihttps://doi.org/10.1007/978-3-031-26078-0
isbn_softcover978-3-031-26080-3
isbn_ebook978-3-031-26078-0Series ISSN 1573-4684 Series E-ISSN 2627-5872
issn_series 1573-4684
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称New Antimicrobials: For the Present and the Future影响因子(影响力)




书目名称New Antimicrobials: For the Present and the Future影响因子(影响力)学科排名




书目名称New Antimicrobials: For the Present and the Future网络公开度




书目名称New Antimicrobials: For the Present and the Future网络公开度学科排名




书目名称New Antimicrobials: For the Present and the Future被引频次




书目名称New Antimicrobials: For the Present and the Future被引频次学科排名




书目名称New Antimicrobials: For the Present and the Future年度引用




书目名称New Antimicrobials: For the Present and the Future年度引用学科排名




书目名称New Antimicrobials: For the Present and the Future读者反馈




书目名称New Antimicrobials: For the Present and the Future读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-22 00:17:59 | 显示全部楼层
发表于 2025-3-22 02:05:09 | 显示全部楼层
I. W. Fonger Querschnittsschwerpunkte ersetzt. .• Es wird vorausgesetzt, dass alle Einwirkungen zeitlich unveränderlich sind, so dass keine dynamischen Effekte auftreten. .• Bei der Formulierung des Gleichgewichts werden die Tragwerksverformungen als vernachlässigbar klein angenommen, d. h. es wird nach der T
发表于 2025-3-22 06:32:10 | 显示全部楼层
Antimicrobial Resistance: A Crisis in the Making,sistant .) and malaria (artemisinin-resistant .), certain viral infections (cytomegalovirus and human immunodeficiency virus), and specific fungal opportunistic pathogens (. and . sp.)..It is estimated that 700,000 deaths occur yearly in the world from AMR infections and projected to escalate to ten
发表于 2025-3-22 12:19:24 | 显示全部楼层
New Glycopeptides: Telavancin, Dalbavancin, and Oritavancines to meet the unmet needs. These new agents, telavancin, dalbavancin, and oritavancin, are more potent and have superior pharmacokinetic profile than the first-generation glycopeptides (vancomycin and teicoplanin). This chapter discusses these new semisynthetic agents’ in vitro activity, pharmacolo
发表于 2025-3-22 16:25:48 | 显示全部楼层
New Tetracyclines: Eravacycline and Omadacyclinea-abdominal infections and omadacycline for community-acquired pneumonia and acute bacterial skin and soft tissue infections. This chapter reviews their chemical structure, pharmacokinetic and pharmacodynamics parameters, microbial activity, ease of resistance, clinical efficacy, adverse effects, an
发表于 2025-3-22 17:25:50 | 显示全部楼层
发表于 2025-3-22 23:15:57 | 显示全部楼层
New Antiviral Agent for Influenza: Baloxaviroral antiviral, baloxavir, was approved in the United States for influenza infection. This chapter reviews the chemistry, antiviral activity, pharmacokinetics, efficacy, and side effects of baloxavir.
发表于 2025-3-23 04:30:55 | 显示全部楼层
Book 2023for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparis
发表于 2025-3-23 09:28:12 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-8 09:01
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表